Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers.
Phase 1
Recruiting
- Conditions
- Healthy VolunteersSafetyTolerabilityPharmacokinetics
- Interventions
- Drug: Placebo (in SAD)Drug: Placebo (MAD)Drug: RCS-21 (in MAD)Drug: RCS-21 (in SAD)
- First Posted Date
- 2024-12-30
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- RNATICS GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT06752122
- Locations
- 🇩🇪
Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany
News
No news found